Synopsis
Synopsis
0
KDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Brentan
2. Dactarin
3. Miconasil Nitrate
4. Miconazole
5. Monistat
6. Nitrate, Miconasil
7. Nitrate, Miconazole
8. R 14,889
9. R-14,889
10. R14,889
1. 22832-87-7
2. Andergin
3. Albistat
4. Aflorix
5. Conofite
6. Florid
7. Dermonistat
8. Micatin
9. Gyno-monistat
10. Epi-monistat
11. Gyno-daktar
12. Miconazole (nitrate)
13. M-zole 7 Dual Pack
14. Brentan
15. Daktarin
16. M-zole 3 Combination Pack
17. Vusion
18. Miconazole 7
19. Priconazole
20. Monistat 3
21. Monistat 5
22. Monistat 7
23. (+/-)-miconazole Nitrate
24. R 14,889
25. Nsc 169434
26. Baza Cream Antifungal
27. R 14889
28. Miconazole 3
29. 1-(2-((2,4-dichlorobenzyl)oxy)-2-(2,4-dichlorophenyl)ethyl)-1h-imidazole Nitrate
30. Monistat 3 Combination Pack
31. Vw4h1cyw1k
32. Nsc-169434
33. R18134 Nitrate
34. Mls000028674
35. Monistat 1 Combination Pack
36. Miconazole 7 Combination Pack
37. 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1h-imidazole; Nitric Acid
38. 1h-imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)-, Mononitrate
39. (+/-)-miconazole Nitrate Salt
40. Deralbine
41. Mezolitan
42. Micotef
43. Smr000058733
44. Crimak
45. Daktarin Talc
46. Monistat (tn)
47. Gyno-daktarin
48. Miconal Ecobi
49. 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole;nitric Acid
50. (+-)-miconazole Nitrate
51. R-14889
52. Lotrimin Af Powder
53. Fungisdin
54. Lotrimin Af Spray Liquid
55. Miconazole 1
56. Lotrimin Af Powder Aerosol
57. Monistat Dual-pak
58. 1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1h-imidazole Nitrate
59. 75319-48-1
60. Monistat 7 Combination Pack
61. Monistat-3 Combination Pack
62. Monistat Cream & Suppositories
63. Nsc169434
64. Miconazole Nitrate Combination Pack
65. Einecs 245-256-6
66. Unii-vw4h1cyw1k
67. Mfcd00058161
68. Lotrimin Af Jock-itch Powder Aerosol
69. Miconazole 3 Combination Pack
70. Baza Cream
71. Monistat Nitrate
72. Sr-01000000271
73. Miconazoli Nitras
74. Miconazol Nitrate
75. 1-(2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl)-1h-imidazole Nitrate
76. Micatin (tn)
77. Miconazole Nitrate [usan:usp:jan]
78. Monistat 3 Combination Pack (prefilled)
79. Miconazole Nitrate Usp
80. Cpd000058733
81. Miconazole Nitrate,(s)
82. Opera_id_1059
83. 1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole Mononitrate
84. Component Of Monistat Cream
85. Baza Cream [vandf]
86. Nsc 169434 Nitrate
87. Chembl1559
88. Schembl15799
89. Mls001148223
90. Mls002548903
91. Spectrum1500413
92. Regid_for_cid_68553
93. Miconazole Nitrate [mi]
94. Miconazole Nitrate [jan]
95. Hms500h18
96. Hy-b0454a
97. Miconazole Nitrate (jp17/usp)
98. Dtxsid50996767
99. Miconazole Nitrate [inci]
100. Miconazole Nitrate [usan]
101. Hms1920n21
102. Hms2091f16
103. Hms2233o22
104. Hms3259m05
105. Hms3655d05
106. Miconazole Nitrate [vandf]
107. Pharmakon1600-01500413
108. Miconazole Nitrate [mart.]
109. Amy11000
110. Bcp13696
111. Miconazole Nitrate [usp-rs]
112. Miconazole Nitrate [who-dd]
113. Miconazole Nitrate [who-ip]
114. Ccg-39756
115. Nsc757119
116. S1956
117. Akos015895065
118. Akos015962190
119. Ab02339
120. Miconazole Nitrate [green Book]
121. Nc00461
122. Nsc-757119
123. 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1h-imidazole Nitrate
124. Imidazole, 1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)-, Mononitrate
125. Miconazole Nitrate [orange Book]
126. Miconazole Nitrate [ep Monograph]
127. Miconazoli Nitras [who-ip Latin]
128. Ncgc00094728-01
129. Ncgc00094728-02
130. Ncgc00094728-03
131. As-13575
132. Bm166180
133. Miconazole Nitrate [usp Monograph]
134. Vusion Component Miconazole Nitrate
135. Easotic Component Miconazole Nitrate
136. Db-046005
137. Ft-0628943
138. Ft-0628944
139. M-206
140. M1769
141. Miconazole Nitrate Component Of Vusion
142. Sw196614-3
143. Aluminum Hydroxideoxide(al(oh)o),hydrate(9ci)
144. Miconazole Nitrate Component Of Easotic
145. C08070
146. D00882
147. Miconazole Nitrate [ema Epar Veterinary]
148. [2,4-dichlorobenzyloxy)phenethyl]imidazole Nitrate
149. (+/-)-miconazole Nitrate Salt, Imidazole Antibiotic
150. Aluminum Hydroxideoxide (al(oh)o), Hydrate (9ci)
151. J-014876
152. Sr-01000000271-2
153. ( Inverted Exclamation Marka)-miconazole Nitrate Salt
154. Q27292045
155. 1-[2,4-dichlorobenzyl)oxy]phenethyl]imidazole Mononitrate
156. 1-(2,4-dichloro-ss-[(2,4-dichlorobenzyl)oxy]phenethyl)imidazole
157. Miconazole Nitrate, British Pharmacopoeia (bp) Reference Standard
158. Miconazole Nitrate, European Pharmacopoeia (ep) Reference Standard
159. 1-[2,4-dichloro-b-[(2,4-dichlorobenzyl)oxy]phenethyl]imidazole Mononitrate
160. Miconazole Nitrate, United States Pharmacopeia (usp) Reference Standard
161. 1-(2,4-dichloro-.beta.-((2,4-dichlorobenezyl)oxy)phenethyl)imidazole Mononitrate
162. 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole;nitric Acid.
163. 1h-imidazole,1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-,mononitrate
164. 1h-imidazole,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-, Mononitrate
165. Imidazole,4-dichloro-.beta.-[(2,4-dichlorobenzyl)oxy]phenethyl]-, Mononitrate
166. (+/-)-miconazole Nitrate Salt, Pharmaceutical Secondary Standard; Certified Reference Material
167. 1h-imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-, Nitrate (1:1)
| Molecular Weight | 479.1 g/mol |
|---|---|
| Molecular Formula | C18H15Cl4N3O4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 478.978717 g/mol |
| Monoisotopic Mass | 476.981667 g/mol |
| Topological Polar Surface Area | 93.1 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 441 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 18 | |
|---|---|
| Drug Name | Monistat 7 combination pack |
| Active Ingredient | Miconazole nitrate |
| Dosage Form | Cream, suppository |
| Route | Topical, vaginal |
| Strength | 2%,100mg |
| Market Status | Over the Counter |
| Company | Insight Pharms |
| 2 of 18 | |
|---|---|
| Drug Name | Monistat-3 combination pack |
| Active Ingredient | Miconazole nitrate |
| Dosage Form | Cream, suppository |
| Route | Topical, vaginal |
| Strength | 2%,200mg |
| Market Status | Over the Counter |
| Company | Insight Pharms |
| 3 of 18 | |
|---|---|
| Drug Name | M-zole 3 combination pack |
| Active Ingredient | Miconazole nitrate |
| Dosage Form | Cream, suppository |
| Route | Topical, vaginal |
| Strength | 2%,200mg |
| Market Status | Over the Counter |
| Company | Actavis Mid Atlantic |
| 4 of 18 | |
|---|---|
| Drug Name | Miconazole 7 |
| Drug Label | Miconazole Nitrate Vaginal Suppositories USP, 200 mg are white to off-white suppositories, each containing the antifungal agent, miconazole nitrate, 1-[2,4-Dichloro--[(2,4- dichlorobenzyl)oxy] phenethyl]-imidazole mononitrate, 200 mg, in a hydrogen... |
| Active Ingredient | Miconazole nitrate |
| Dosage Form | Cream |
| Route | Vaginal |
| Strength | 2% |
| Market Status | Over the Counter |
| Company | Actavis Mid Atlantic |
| 5 of 18 | |
|---|---|
| Drug Name | Miconazole nitrate |
| Active Ingredient | Miconazole nitrate |
| Dosage Form | Cream; Suppository; Cream, suppository |
| Route | topical, vaginal; Vaginal; Topical, vaginal |
| Strength | 200mg; 100mg; 2%; 4%; 2%,1.2gm |
| Market Status | Over the Counter; Prescription |
| Company | Taro; Perrigo R And D; Actavis Mid Atlantic; Perrigo; G And W Labs |
| 6 of 18 | |
|---|---|
| Drug Name | Miconazole nitrate combination pack |
| Active Ingredient | Miconazole nitrate |
| Dosage Form | Cream, suppository |
| Route | Topical, vaginal |
| Strength | 2%,200mg |
| Market Status | Over the Counter |
| Company | Perrigo |
| 7 of 18 | |
|---|---|
| Drug Name | Monistat 3 |
| Drug Label | MONISTAT 3 Vaginal Suppositories are white to off-white suppositories, each containing the antifungal agent, miconazole nitrate, 1-[2,4-Dichloro--[(2,4-dichlorobenzyl)oxy]phenethyl]-imidazole mononitrate, 200 mg, in a hydrogenated vegetable oil bas... |
| Active Ingredient | Miconazole nitrate |
| Dosage Form | Cream; Suppository |
| Route | Vaginal |
| Strength | 200mg; 4% |
| Market Status | Over the Counter; Prescription |
| Company | Insight Pharms |
| 8 of 18 | |
|---|---|
| Drug Name | Monistat 3 combination pack |
| Active Ingredient | Miconazole nitrate |
| Dosage Form | Cream |
| Route | Topical, vaginal |
| Strength | 2%,4% |
| Market Status | Over the Counter |
| Company | Insight Pharms |
| 9 of 18 | |
|---|---|
| Drug Name | Monistat 7 |
| Active Ingredient | Miconazole nitrate |
| Dosage Form | Cream; Suppository |
| Route | Vaginal |
| Strength | 100mg; 2% |
| Market Status | Over the Counter |
| Company | Insight Pharms |
| 10 of 18 | |
|---|---|
| Drug Name | Monistat 7 combination pack |
| Active Ingredient | Miconazole nitrate |
| Dosage Form | Cream, suppository |
| Route | Topical, vaginal |
| Strength | 2%,100mg |
| Market Status | Over the Counter |
| Company | Insight Pharms |
| 11 of 18 | |
|---|---|
| Drug Name | Monistat-3 combination pack |
| Active Ingredient | Miconazole nitrate |
| Dosage Form | Cream, suppository |
| Route | Topical, vaginal |
| Strength | 2%,200mg |
| Market Status | Over the Counter |
| Company | Insight Pharms |
| 12 of 18 | |
|---|---|
| Drug Name | M-zole 3 combination pack |
| Active Ingredient | Miconazole nitrate |
| Dosage Form | Cream, suppository |
| Route | Topical, vaginal |
| Strength | 2%,200mg |
| Market Status | Over the Counter |
| Company | Actavis Mid Atlantic |
| 13 of 18 | |
|---|---|
| Drug Name | Miconazole 7 |
| Drug Label | Miconazole Nitrate Vaginal Suppositories USP, 200 mg are white to off-white suppositories, each containing the antifungal agent, miconazole nitrate, 1-[2,4-Dichloro--[(2,4- dichlorobenzyl)oxy] phenethyl]-imidazole mononitrate, 200 mg, in a hydrogen... |
| Active Ingredient | Miconazole nitrate |
| Dosage Form | Cream |
| Route | Vaginal |
| Strength | 2% |
| Market Status | Over the Counter |
| Company | Actavis Mid Atlantic |
| 14 of 18 | |
|---|---|
| Drug Name | Miconazole nitrate |
| Active Ingredient | Miconazole nitrate |
| Dosage Form | Cream; Suppository; Cream, suppository |
| Route | topical, vaginal; Vaginal; Topical, vaginal |
| Strength | 200mg; 100mg; 2%; 4%; 2%,1.2gm |
| Market Status | Over the Counter; Prescription |
| Company | Taro; Perrigo R And D; Actavis Mid Atlantic; Perrigo; G And W Labs |
| 15 of 18 | |
|---|---|
| Drug Name | Miconazole nitrate combination pack |
| Active Ingredient | Miconazole nitrate |
| Dosage Form | Cream, suppository |
| Route | Topical, vaginal |
| Strength | 2%,200mg |
| Market Status | Over the Counter |
| Company | Perrigo |
| 16 of 18 | |
|---|---|
| Drug Name | Monistat 3 |
| Drug Label | MONISTAT 3 Vaginal Suppositories are white to off-white suppositories, each containing the antifungal agent, miconazole nitrate, 1-[2,4-Dichloro--[(2,4-dichlorobenzyl)oxy]phenethyl]-imidazole mononitrate, 200 mg, in a hydrogenated vegetable oil bas... |
| Active Ingredient | Miconazole nitrate |
| Dosage Form | Cream; Suppository |
| Route | Vaginal |
| Strength | 200mg; 4% |
| Market Status | Over the Counter; Prescription |
| Company | Insight Pharms |
| 17 of 18 | |
|---|---|
| Drug Name | Monistat 3 combination pack |
| Active Ingredient | Miconazole nitrate |
| Dosage Form | Cream |
| Route | Topical, vaginal |
| Strength | 2%,4% |
| Market Status | Over the Counter |
| Company | Insight Pharms |
| 18 of 18 | |
|---|---|
| Drug Name | Monistat 7 |
| Active Ingredient | Miconazole nitrate |
| Dosage Form | Cream; Suppository |
| Route | Vaginal |
| Strength | 100mg; 2% |
| Market Status | Over the Counter |
| Company | Insight Pharms |
14-alpha Demethylase Inhibitors
Compounds that specifically inhibit STEROL 14-DEMETHYLASE. A variety of azole-derived ANTIFUNGAL AGENTS act through this mechanism. (See all compounds classified as 14-alpha Demethylase Inhibitors.)
Cytochrome P-450 CYP2C9 Inhibitors
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2C9. (See all compounds classified as Cytochrome P-450 CYP2C9 Inhibitors.)
Antifungal Agents
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)
Cytochrome P-450 CYP3A Inhibitors
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP3A. (See all compounds classified as Cytochrome P-450 CYP3A Inhibitors.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - CREAM;VAGINAL - 2%
USFDA APPLICATION NUMBER - 17450
DOSAGE - CREAM, SUPPOSITORY;TOPICAL, VAGINAL ...DOSAGE - CREAM, SUPPOSITORY;TOPICAL, VAGINAL - 2%,200MG
USFDA APPLICATION NUMBER - 20670
DOSAGE - OINTMENT;TOPICAL - 0.25%;81.35%;15%
USFDA APPLICATION NUMBER - 21026
DOSAGE - CREAM, INSERT;TOPICAL, VAGINAL - 2%,...DOSAGE - CREAM, INSERT;TOPICAL, VAGINAL - 2%,1.2GM
USFDA APPLICATION NUMBER - 21308
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Evonik
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kewpie Corporation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Minbiotech
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]BioSpectra
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Esteem Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lubrizol Life Science Health
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nippon Fine Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shandong Focus Biotechnology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Topical
Coating Systems & Additives
Solubilizers
Thickeners and Stabilizers
Fillers, Diluents & Binders
Controlled & Modified Release
Emulsifying Agents
Parenteral
Direct Compression
Surfactant & Foaming Agents
Granulation
Film Formers & Plasticizers
Co-Processed Excipients
Disintegrants & Superdisintegrants
Lubricants & Glidants
Taste Masking
Rheology Modifiers
API Stability Enhancers
Chewable & Orodispersible Aids
Empty Capsules
Vegetarian Capsules
Coloring Agents
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
23
PharmaCompass offers a list of Miconazole Nitrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Miconazole Nitrate manufacturer or Miconazole Nitrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Miconazole Nitrate manufacturer or Miconazole Nitrate supplier.
PharmaCompass also assists you with knowing the Miconazole Nitrate API Price utilized in the formulation of products. Miconazole Nitrate API Price is not always fixed or binding as the Miconazole Nitrate Price is obtained through a variety of data sources. The Miconazole Nitrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Conofite manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Conofite, including repackagers and relabelers. The FDA regulates Conofite manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Conofite API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Conofite manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Conofite supplier is an individual or a company that provides Conofite active pharmaceutical ingredient (API) or Conofite finished formulations upon request. The Conofite suppliers may include Conofite API manufacturers, exporters, distributors and traders.
click here to find a list of Conofite suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Conofite DMF (Drug Master File) is a document detailing the whole manufacturing process of Conofite active pharmaceutical ingredient (API) in detail. Different forms of Conofite DMFs exist exist since differing nations have different regulations, such as Conofite USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Conofite DMF submitted to regulatory agencies in the US is known as a USDMF. Conofite USDMF includes data on Conofite's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Conofite USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Conofite suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Conofite Drug Master File in Japan (Conofite JDMF) empowers Conofite API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Conofite JDMF during the approval evaluation for pharmaceutical products. At the time of Conofite JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Conofite suppliers with JDMF on PharmaCompass.
A Conofite CEP of the European Pharmacopoeia monograph is often referred to as a Conofite Certificate of Suitability (COS). The purpose of a Conofite CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Conofite EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Conofite to their clients by showing that a Conofite CEP has been issued for it. The manufacturer submits a Conofite CEP (COS) as part of the market authorization procedure, and it takes on the role of a Conofite CEP holder for the record. Additionally, the data presented in the Conofite CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Conofite DMF.
A Conofite CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Conofite CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Conofite suppliers with CEP (COS) on PharmaCompass.
A Conofite written confirmation (Conofite WC) is an official document issued by a regulatory agency to a Conofite manufacturer, verifying that the manufacturing facility of a Conofite active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Conofite APIs or Conofite finished pharmaceutical products to another nation, regulatory agencies frequently require a Conofite WC (written confirmation) as part of the regulatory process.
click here to find a list of Conofite suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Conofite as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Conofite API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Conofite as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Conofite and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Conofite NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Conofite suppliers with NDC on PharmaCompass.
Conofite Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Conofite GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Conofite GMP manufacturer or Conofite GMP API supplier for your needs.
A Conofite CoA (Certificate of Analysis) is a formal document that attests to Conofite's compliance with Conofite specifications and serves as a tool for batch-level quality control.
Conofite CoA mostly includes findings from lab analyses of a specific batch. For each Conofite CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Conofite may be tested according to a variety of international standards, such as European Pharmacopoeia (Conofite EP), Conofite JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Conofite USP).
